Buddha Genomics Center Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 1 Year 1 Day
About Buddha Genomics Center
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajani Kantha, Pruthvi Thammaiah, and Usha Shivanna serve as directors at the Company.
- CIN/LLPIN
U82990KA2023PTC182440
- Company No.
182440
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Buddha Genomics Center?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajani Kantha  | Managing Director | 20-Dec-2023 | Current |
| Pruthvi Thammaiah | Managing Director | 20-Dec-2023 | Current |
| Usha Shivanna | Managing Director | 20-Dec-2023 | Current |
Board Members(0)
| Name | Designation | Appointment Date | Status |
|---|
Financial Performance and Corporate Structure Insights of Buddha Genomics Center.
Enhance accessibility to Buddha Genomics Center's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Buddha Genomics Center?
Unlock access to Buddha Genomics Center's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Bengaluru Genomics Center Private LimitedActive 9 years 10 daysRajani Kantha, Pruthvi Thammaiah and 1 more are mutual person
- Ripuhara Agro Private LimitedActive 9 years 5 months
Rajani Kantha and Pruthvi Thammaiah are mutual person
- Bioxverse Technologies Private LimitedActive 11 months 9 days
Rajani Kantha, Pruthvi Thammaiah and 1 more are mutual person
- Scientech Cropcare Private LimitedActive 14 years 3 months
Rajani Kantha and Pruthvi Thammaiah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Buddha Genomics Center?
Unlock and access historical data on people associated with Buddha Genomics Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Buddha Genomics Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Buddha Genomics Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.